NCT03414840

Assessment of Change in Atherosclerotic Plaque by Serial CCTA

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 400 (estimated)
• Sponsor: Yonsei University · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

Assessment of Change in AtheROSclerotic Plaque by Serial CCTA (ACROSS) is designed as a prospective observational study which aim is to demonstrate the effect of statins on coronary atherosclerosis, assessed by quantitative analysis of CCTA.

Conditions

• Coronary Artery Disease
• Hydroxymethylglutaryl-CoA Reductase Inhibitors
• Coronary Arteriosclerosis

Interventions

Type	Name	Description
DRUG	Atorvastatin	Patients diagnosed with coronary artery disease by CCTA be enrolled. Among enrolled patients, patients who is indicated to statin treatment according to the current ACC/AHA guideline will be treated with atorvastatin.

Timeline

• Start date: 2018-04-01
• Primary completion: 2020-02-28
• Completion: 2020-10-31
• First posted: 2018-01-30
• Last updated: 2018-06-29

Locations

1 site across 1 country: South Korea

Regulatory

• FDA-regulated drug study